The University of Chicago Header Logo

Connection

Mark Talamonti to Cyclosporine

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Cyclosporine.
Mark Talamonti
Connection Strength
0.089
Cyclosporine
  1. Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension. Dermatology. 2011; 222(3):250-5.
    View in: PubMed
    Score: 0.089
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.